We describe the first case report of bacteremia due to Aeromonas veronii biotype veronii. The infection occurred in a 77-year-old man suffering from multiple underlying conditions which included cancer of the sigmoid colon. Because of the unusual biochemical phenotype of this group 0/129 (10 ,ug and 150 ,ug), and it grew in nutrient broth in the absence (0%) and presence (3%) of NaCl. Biochemically (all reactions were positive within 24 h unless otherwise stated; negative reactions were held for 7 days) this organism was ornithine and lysine decarboxylase positive and arginine dihydrolase negative, and it produced acid from D-glucose, maltose, sucrose, trehalose, D-mannitol, glycerol, salicin, cellobiose, a-methyl-D-glucoside, and hydrolyzed esculin. Strain 93A-7534 did not produce acid from L-arabinose, L-rhamnose, raffinose, D-sorbitol, melibiose, or lactose. On the basis of these test results the strain was identified asA. veronii (1).
liver and hepatomegaly. The patient suffered multisystem organ failure 2 other Aeromonas groups, such as A. hydrophila and A. veronii (DNA group 8). When further case reports documenting A. veronii (DNA group 10) polymicrobic or monomicrobic sepsis become available, a clearer picture regarding the relative pathogenicity of this species in humans will become available. Probably the most important diagnostic point concerning this bacterium is its possible misidentification as V cholerae because of its ornithine decarboxylase reaction. This is of considerable significance, since the possible isolation of V. cholerae from any clinical or environmental site can activate a number of public health measures to control the spread of such an organism. These misidentifications can be minimized if laboratories perform additional tests, such as that for production of gas from glucose and the string reaction (0.5% deoxycholate), to differentiate V cholerae from A. veronii (DNA group 10). Useful differential tests to distinguish these two species are listed in Table 1 . Although 0/129 susceptibility has been an extremely useful test in the past, its usefulness may be short-lived, as an increasing number of both V cholerae 01 and V cholerae non-O1 strains are becoming resistant to this pteridine compound on a global basis. Such phenotypic changes will require additional vigilance by laboratory personnel in order to avoid laboratory misidentifications of major clinical importance.
